Frank H. Valone

2016

In 2016, Frank H. Valone earned a total compensation of $733.6K as Senior Fellow, Clinical Development formerly Chief Medical Officer at FibroGen, a 75% decrease compared to previous year.

Compensation breakdown

Option Awards$228,732
Salary$257,074
Stock Awards$228,123
Other$19,704
Total$733,633

Valone received $257.1K in salary, accounting for 35% of the total pay in 2016.

Valone also received $228.7K in option awards, $228.1K in stock awards and $19.7K in other compensation.

Rankings

In 2016, Frank H. Valone's compensation ranked 9,679th out of 14,075 executives tracked by ExecPay. In other words, Valone earned more than 31.2% of executives.

ClassificationRankingPercentile
All
9,679
out of 14,075
31st
Division
Manufacturing
3,749
out of 5,486
32nd
Major group
Chemicals And Allied Products
1,305
out of 1,900
31st
Industry group
Drugs
1,038
out of 1,543
33rd
Industry
Pharmaceutical Preparations
814
out of 1,173
31st
Source: SEC filing on April 24, 2017.

Valone's colleagues

We found three more compensation records of executives who worked with Frank H. Valone at FibroGen in 2016.

2016

Thomas Neff

FibroGen

Chief Executive Officer

2016

K Yu

FibroGen

Chief Medical Officer

2016

Pat Cotroneo

FibroGen

Chief Financial Officer

You may also like